Global Immunomodulators Market Report and Forecast 2024-2032

Global Immunomodulators Market Outlook

The global immunomodulators market attained a value of about USD 207.25 billion in 2023. The market is further expected to grow in the forecast period of 2024-2032 at a CAGR of 5.8% to reach nearly USD 343.62 billion by 2032.     

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

North America to Contribute Significant Share in the Global Immunomodulators Industry

North America is a significant market for the global immunomodulatory industry because of the growing geriatric population in this region. Due to the surging incidence of chronic diseases like sclerosis, Crohn’s disease, ulcerative colitis in the United States, demand from end-users for immunomodulator-based treatment and the high therapy cost associated with the treatment of sclerosis are anticipated to drive revenue growth in this segment. Further, awareness among the masses and government initiatives are also boosting the immunomodulator industry. Europe, on the other hand, is expected to witness substantial growth backed by the increasing sales of immunosuppressant products in the region.

Impact of COVID-19

COVID-19 has shown its footprint across the globe, severely affecting many economies and industries due to lockdowns and several restrictions. However, coronavirus has positively affected the immunomodulator industry, owing to rise in the sales of products with respect to the emergency. Various pharmaceutical companies are trying to balance demand and supply to keep their sales flow smooth. These pharmaceutical companies are now trying to invest more in quality control, strengthen their research and development departments, and magnify supply chain management, which is expected to boost the market growth over the forecast period.

Immunomodulators: Market Segmentation

Immunomodulators are substances that are used to regulate or normalise the immunity system. It supports immune function by modifying, generally in a healthy way, the immune system’s response to a threat. They are directed to enhance the immune response against infectious diseases, tumours, primary or secondary immunodeficiency, and alterations in antibody transfer, among others.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The major types of immunomodulators on the basis of product are:

• Immunosuppressants
  • Antibodies
  • Calcineurin Inhibitors
  • Glucocorticoid
  • Antimetabolites
  • Others
• Immunostimulants
  • Vaccines 
  • Antibodies 
  • Others

The market can be broadly categorised on the basis of its applications into:

• Oncology 
• Respiratory 
• HIV 
• Others 

The EMR report looks into the regional markets of immunomodulators like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Increase in the Number of Chronic Diseases is Driving the Immunomodulator Industry

The key contributory factor in the growth of the global immunomodulators industry is the increasing incidence of chronic diseases, including asthma, allergic conditions, cancer, and multiple sclerosis. Further, some of the factors contributing to the growth of the immunomodulator industry include the prevailing cases of organ transplantation, increasing adoption of an early immunomodulator therapy for the Crohn’s disease treatment, rising awareness about inflammatory bowel diseases, growing autoimmune diseases, and increasing development of drug resistance, which is resulting in the rise of immunomodulators usage.

However, the market growth may hinder due to the presence of stringent regulatory approval procedures, along with the high cost of the therapy and the immunomodulator products. Further, adverse effects of immunomodulatory drugs, such as pain, inflammation, epilepsy, are likely to restrain the market growth during the forecast period.

Key Industry Players in the Global Immunomodulators Market

The report presents a detailed analysis of the following key players in the global immunomodulators market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

• F. Hoffmann-La Roche Ltd. 
• Amgen, Inc. 
• Abbott Laboratories 
• Novartis AG 
• Biogen Inc. 
• Others 

The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.

Key Highlights of the Report